Inositol Requiring Enzyme 1 alpha (IRE1α) is an ER-transmembrane endonuclease that is activated in response to ER stress as part of the unfolded protein response (UPR). Chronic activation of the UPR has been implicated in the pathogenesis of many common disease including diabetes, cancer and neurological pathologies such as Huntington's and Alzheimer's disease.
Introduction
The endoplasmic reticulum (ER) is the site for the synthesis and processing of secretory and membrane proteins. Perturbations in ER homeostasis that interfere with protein folding result in the activation of an adaptive response termed the Unfolded Protein Response (UPR) [1, 2] .
Chronic activation of the UPR has been implicated in many human pathologies including infectious, neurodegenerative, autoimmune, and metabolic conditions [3] [4] [5] .
The UPR is classically mediated by three ER-transmembrane proteins: PKR-like ER kinase (PERK), activating transcription factor 6 (ATF6), and inositol requiring enzyme 1α (IRE1α).
IRE1α senses perturbations in ER homeostasis via its luminal domain which results in a conformational change [6, 7] . This in turn promotes oligomerisation and the activation of its cytoplasmic protein kinase and RNAse domain. Activation of IRE1α leads to the cleavage and subsequent ligation of the mRNA encoding the X-box transcription factor-1 (XBP1) resulting in a frame shift and the synthesis of a truncated and transcriptionally active spliced form of XBP1 (XBP1s) [8] . In an attempt to relieve ER stress, XBP1s enhances the transcription of genes important in facilitating protein folding including the ER chaperone glucose regulated protein 78 [6, 9] . However, chronic IRE1α activation can lead to programmed cell death through the activation of multiple signalling pathways (e.g. [6, [10] [11] [12] ).
A number of small molecule inhibitors of IRE1α have been identified and characterised including 7-hydroxy-4-methyl-2-oxo-2H-chromene-8-carbaldehyde (4µ8C) [13] . 4µ8C is an aromatic aldehyde that binds to IRE1α's RNAse domain and inhibits its activity. This inhibitor has provided valuable insights into defining the mechanism of action of IRE1α in both cellular physiology and pathophysiology (e.g. [13] [14] [15] [16] [17] [18] [19] ) . 4µ8C has also been used in animal studies [20] although its effectiveness in vivo is uncertain. A recent study investigating the effect of 4µ8C on insulin secretion has highlighted the potential of this inhibitor to have off-target effects [21] .
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Consistent with this, in this report we demonstrate that 4µ8C not only inhibits IRE1α but also acts as a potent scavenger of ROS both in cell free assays and in cultured cells. In the light of this discovery conclusions reached using 4µ8C as a specific IRE1α RNAse inhibitor should be carefully considered.
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Experimental
Cell culture. Mouse Insulinoma 6 (MIN6) cells [22] were used between passages 25 and 35 at ~80% confluence and cultured as previously described [23] . Mouse microvascular cerebral endothelial cells, bEnd.3 [24] were used between passage 24-34 (ATCC CRL-2299) and cultured in Dulbecco's Modified Eagle Medium (Life Technology, Australia) supplemented with 10% fetal bovine serum (FBS; Bovogen Australia), at 37°C and 5% CO2.
Quantification of superoxide in a cell-free enzyme system. The xanthine/xanthine oxidase cellfree assay coupled with 5 μmol/L lucigenin-enhanced chemiluminescence [25] was used to assess the superoxide scavenging properties of 4µ8C. Briefly, to initiate the reaction, xanthine oxidase (50mU/ml) was added to Krebs-Hepes solution (NaCl 99 mmol/L, KCl 4.7 mmol/L, KH2PO4 10 mmol/L, MgSO4 1.2 mmol/L, NaHCO3 25 mmol/L, glucose 11 mmol/L, CaCl2 2.5 mmol/L, and EDTA 0.026 mmol/L, pH 7.4) containing xanthine (100 μmol/L) and lucigenin (5μmol/L). Where indicated experiments were performed in the absence or presence of superoxide dismutase (SOD; 250U/ml), 4µ8C (3nM -30µM), DMSO ((0.1%) vehicle for 4µ8C), or Tiron (0.3 -3000µM). Superoxide counts were measured using a BMG Clariostar plate reader (BMG Labtech, Melbourne, Australia). Background counts were then subtracted, and the superoxide level was expressed as relative luminescence units (RLU).
Quantification of cellular superoxide levels. Superoxide levels were measured using L-012 (100 µmol/l) enhanced chemiluminescence as previously described [26] . Cells were plated on Statistical analysis Data are expressed as mean +/-SEM, unless otherwise stated. Data were analysed by one-way ANOVA followed by Tukey's post-hoc test for multiple comparison between means using Prism 6 (GraphPad Software, USA). Differences were considered statistically significant at p < 0.05.
Results
4µ8C is a potent superoxide scavenger in a cell free assay. While studying the role of angiotensin II (AngII), an inducer of ROS, in the development of beta cell dysfunction [26] we observed that the commonly used IRE1α inhibitor 7-hydroxy-4-methyl-2-oxo-2H-chromene-8-carbaldehyde (4µ8C) inhibited, not only the activation of IRE1α, but also PERK, indicating that 4µ8C may have off-target effects (unpublished observations). Many naturally occurring antioxidants are polyphenolic compounds that act as free radical scavengers [27] . As 4µ8C [13] ( Figure 1a ) is a polyphenolic compound it also has the potential to act as a free radical scavenger. To investigate this possibility, cell-free xanthine/xanthine oxidase assays were performed using the chemiluminescent probe lucigenin. As expected the addition of xanthine oxidase to a solution containing xanthine and lucigenin led to a rapid increase in superoxide levels (figure 1b), which was abolished in the presence of SOD. Thus confirming that the reaction between xanthine and xanthine oxidase generates superoxide [25] . Furthermore, the addition of 4µ8C alone (i.e. in the absence of xanthine oxidase) had no effect on relative luminescence (figure 1b). Next, we measured superoxide levels, in the presence or absence of either increasing concentrations of the IRE1α inhibitor 4µ8C or as a positive control, tiron, a classical ROS scavenger [28] . 4µ8C (3mM to 30µM) ( Figure 1c ) or tiron (0.3µM to 3mM) ( Figure 1d ) reduced superoxide levels generated by the xanthine/xanthine oxidase cell-free assay in a concentration-dependent manner. Tiron inhibited xanthine/xanthine oxidase superoxide production with an IC50 of 7.3x10 -6 M, whereas 4µ8C inhibited superoxide production with an IC50 of 2.0x10 -7 M (figure 1e). Therefore, 4µ8C is a more potent superoxide scavenger than tiron in this cell-free enzyme assay.
4µ8C inhibits angiotensin II-induced superoxide production in pancreatic beta-cells and brain endothelial cells. Angiotensin II (AngII) increases cellular superoxide production by activating the NADPH oxidases (NOX) via the angiotensin type 1 receptor (AT1R) [29] .
Therefore, to determine whether 4µ8C also acts as an antioxidant in cells, the mouse pancreatic beta-cell line, MIN6, and the mouse cerebral endothelial cell line, bEnd3, were treated with AngII in the presence or absence of 4µ8C (30µM) or, as control, the AT1R antagonist irbesartan (IRB). Superoxide levels were then measured using the luminol-based To formally demonstrate that AngII-generated superoxide production was through the activation of NOX rather than ER stress-induced IRE1α activation, MIN6 and bEnd.3 cells were treated with AngII in the presence or absence of two NOX inhibitors, diphenyleneiodonium (DPI) and apocynin [30] (Figure 2c and d) . AngII treatment caused an increase in superoxide production which was effectively inhibited by both of the NOX inhibitors. This provides evidence that AngII-induced superoxide was generated through the activation of NOX and not IRE1α activation. with an IC50 of 6.89µM [13] , 4µ8C antioxidant activity is more potent than it ability to inhibit IRE1α RNAse activity.
4µ8C inhibits AngII-induced ROS production in MIN6 and bEnd.3 cells. As further evidence that 4µ8C is an antioxidant in mammalian cells, MIN6 and bEnd.3 cells were treated with AngII in the presence and absence of 4µ8C and changes in intracellular ROS was detected using 2',7' -dichlorofluorescin diacetate (CM-H2DCFDA), a fluorogenic dye that reacts with hydroxyl, hydrogen peroxide, peroxynitrite, and to a lesser extent superoxide [31] . Because hydrogen peroxide is a downstream product of superoxide, CM-H2DCFDA fluorescence is often used to implicate superoxide production [31] . Using CM-H2DCFDA, we confirmed that AngII increases ROS production in both MIN6 cells (Figure 4a ) and bEnd.3 cells (Figure 4b ), and that this is inhibited by apocynin. Importantly, AngII stimulates ROS production was also inhibited by 4µ8C (30µM). Thus 4µ8C acts as a ROS scavenger in cultured mammalian cells.
Discussion
Cell-permeable low-molecular weight inhibitors are used extensively to understand the role of specific enzymes in cellular physiology. Unfortunately, these compounds often lack specificity and display multiple off target effects that can lead to the misinterpretation of data. Our data demonstrates that 4µ8C, at concentrations widely used to inhibit IRE1α activity, also acts as a potent ROS scavenger both in a cell free assay and in cultured cells. Importantly, no other studies have shown that 4µ8C acts as a ROS scavenger.
The IC50 values for scavenging ROS by 4u8C differed in the two cell types used in this study.
Although this may reflect the relative ability of AngII to stimulate ROS in these cells, comparison of ROS production between different cell types is difficult due to differences in, for example, ROS detector probe loading into the cell. Regardless, the effectiveness of the IRE1α inhibitor as a ROS scavenger is likely to be dependent on the amount of ROS being generated. In cells, such as phagocytes, that generate high concentration of ROS, the IC50 of the inhibitor against IRE1α RNAse activity may be greater than its IC50 for scavenging ROS.
Interestingly, 4u8C has been used in macrophages to provide evidence for the role of IRE1α in ROS-dependent killing of bacteria [32] . Whether some or all of the effects of 4u8C reported on ROS-dependent killing were mediated by the antioxidant properties of 4u8C, as demonstrated in the report, is unclear but again highlights the importance of this study.
Recently, Sato et al examined the role of IRE1α on insulin secretion in pancreatic β-cells using 4u8C. They discovered that 4u8C inhibited insulin secretion even in cells lacking the IRE1α
RNAse domain demonstrating that 4u8C is able to block insulin secretion independent of the IRE1α/XBP1 pathway [21] . Given the results presented in this report, it is possible that the inhibitory effects of 4u8C on insulin secretion are through the scavenging of ROS.
4µ8C ability to act as a potent ROS scavenger is likely due to its coumarin type conjugated structure (Figure 1a) , which can enable stabilisation of the free radical either by donation of a hydrogen atom or an electron [33] . This stabilisation is a result of the numerous resonance forms that are possible once the 4µ8C radical is formed, i.e. the 4u8c radical is resonance delocalised.
This off-target effect is a particular problem for researchers interested in delineating the role of IRE1 in ER stress responses, as oxidative stress can induce ER stress and conversely ER stress can promote oxidative stress [1, 34] . Despite the potential problems of interpreting data using 4µ8C, off-target effects of low molecular cell permeable inhibitors can be advantageous in a clinical setting. For example, Gleevec (Imatinib), initially developed as an inhibitor of BCRAbl, was later found to also inhibits the c-kit and platelet-derived growth factor receptor-A.
This off target effect proved advantageous in its use as a treatment of gastrointestinal stromal tumour (GIST) [35] . Given that we demonstrate that 4µ8C can also act as a potent antioxidant this may prove therapeutically advantageous for the treatment of pathologies that are thought to be caused by, or exacerbated by, both oxidative and ER stress e.g. endothelial dysfunction or diabetes [1, 4, [36] [37] [38] . Therefore it is possible that 4µ8C, or a more pharmokinetically favourable structural analogue, may prove to have therapeutic value against such diseases.
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